Literature DB >> 3912368

Abnormality of the post-proline-cleaving enzyme activity in mice with systemic lupus erythematosus-like syndrome.

T Aoyagi, T Wada, F Kojima, M Nagai, M Okubo, Y Masaki, H Umezawa.   

Abstract

Previous studies indicated the importance of hydrolytic enzymes in the pathogenesis of autoimmune diseases. In the present study, we examined the activities of such enzymes in various organs of the hybrids of the New Zealand Black and New Zealand White mouse (NZB/W mouse) as a laboratory model of human systemic lupus erythematosus. Of the 18 enzymatic activities tested, the activities of the post-proline-cleaving enzyme showed a particular behavior in the spleen of NZB/W mouse. The enzymatic activity progressively increased with age in contrast to the reverse tendency in the control. This phenomenon was not found in any organs other than the spleen. The activity of this enzyme showed a high level of correlation to that of proline-iminopeptidase in most organs tested from control animals. However, these correlations were almost completely absent in the spleen of NZB/W mice. This may suggest an important pathogenetic role for the post-proline-cleaving enzyme in immunological disturbances in this model animal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3912368

Source DB:  PubMed          Journal:  J Appl Biochem        ISSN: 0161-7354


  4 in total

1.  Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease.

Authors:  T Aoyagi; T Wada; M Nagai; F Kojima; S Harada; T Takeuchi; H Takahashi; K Hirokawa; T Tsumita
Journal:  Experientia       Date:  1990-01-15

Review 2.  Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.

Authors:  Uros V Djekic; Amit Gaggar; Nathaniel M Weathington
Journal:  Pharmacol Ther       Date:  2008-10-31       Impact factor: 12.310

3.  The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients.

Authors:  Jofre Tenorio-Laranga; Carmina Montoliu; Amparo Urios; Vicente Hernandez-Rabaza; Hanan Ahabrach; J Arturo García-Horsman; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2015-09-30       Impact factor: 8.322

4.  Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages.

Authors:  R A Olivo; N G Nascimento; C F P Teixeira; P F Silveira
Journal:  Clin Dev Immunol       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.